Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,200 | 2 | 46.6% |
| Honoraria | $2,000 | 1 | 42.4% |
| Travel and Lodging | $346.48 | 3 | 7.3% |
| Food and Beverage | $172.66 | 2 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fisher Scientific Company L.L.C. | $2,417 | 5 | $0 (2023) |
| Roche Diagnostics Corporation | $1,200 | 1 | $0 (2020) |
| Nabriva Therapeutics, plc | $1,102 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,346 | 4 | Fisher Scientific Company L.L.C. ($2,346) |
| 2020 | $2,302 | 3 | Roche Diagnostics Corporation ($1,200) |
| 2019 | $70.42 | 1 | Fisher Scientific Company L.L.C. ($70.42) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Travel and Lodging | In-kind items and services | $212.88 | General |
| Category: Infectious Disease | ||||||
| 10/12/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Honoraria | In-kind items and services | $2,000.00 | General |
| Category: Infectious Disease | ||||||
| 10/12/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Travel and Lodging | In-kind items and services | $32.48 | General |
| Category: Infectious Disease | ||||||
| 08/29/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Travel and Lodging | In-kind items and services | $101.12 | General |
| Category: Infectious Disease | ||||||
| 11/16/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $102.24 | General |
| Category: Antibiotic | ||||||
| 05/05/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Antibiotic | ||||||
| 03/26/2020 | Roche Diagnostics Corporation | CD cobas Reagents (Device) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Centralized Diagnostics | ||||||
| 02/25/2019 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $70.42 | General |
| Category: Infectious Disease | ||||||
About Dr. Jason Zemmel D'amore, MD
Dr. Jason Zemmel D'amore, MD is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831228469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Zemmel D'amore, MD has received a total of $4,719 in payments from pharmaceutical and medical device companies, with $2,346 received in 2023. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($2,200).
Practice Information
- Specialty Emergency Medicine
- Location Manhasset, NY
- Active Since 03/02/2007
- Last Updated 04/18/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1831228469
Products in Payments
- Procalcitonin (Device) $2,417
- CD cobas Reagents (Device) $1,200
- Xenleta (Drug) $1,102
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Dr. Tadeusz Korszun, Md, MD
Emergency Medicine — Payments: $2,243
David Silver, Md, MD
Emergency Medicine — Payments: $1,153
Dr. Robert Gekle, M.d, M.D
Emergency Medicine — Payments: $1,099